Phase 2 Completed N=30 Randomized Double-blind Treatment

Topical Treatment of Under Eye Dark Circles and Swelling

Edema

Source: ClinicalTrials.gov NCT01172522 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2015

Primary outcomePrimary: Number of Participants Who Showed Improvement in Under Eye Swelling and Dark Circles Relative to Baseline Per Intervention — 0; 0 participants — p==1

Summary

This study examines topical treatment of under eye circles and swelling.

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants Who Showed Improvement in Under Eye Swelling and Dark Circles Relative to Baseline Per Intervention	0; 0	=1

Eligibility Criteria

Inclusion Criteria

Under eye dark circles and swelling

Exclusion Criteria

Under age 18
Allergy to tested medicines

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01172522). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.